MGIM
HALO icon

M&G Investment Management’s Halozyme HALO Stock Holding History

M&G Investment Management’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-36,688
Closed -$1.5K – 600
2021
Q3 		$1.5K Hold
36,688
– – ﹤0.01% 563
2021
Q2 		$1.65K Buy
+36,688
New +$1.62M ﹤0.01% 543

Other funds holding HALO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

M&G Investment Management's HALO Position: Q4 2021 in Review

M&G Investment Management sold out of Halozyme (HALO) in Q4 2021, closing a stake of 36,688 shares — an estimated $1.5K sold.

M&G Investment Management first reported a position in HALO in Q2 2021 and held it in 2 quarters. The position peaked at $1.65K in Q2 2021. 324 funds tracked by Wall St. Rank hold HALO as of Q4 2021.

  • M&G Investment Management reported no remaining Halozyme position as of Q4 2021 after selling out during the quarter.
  • M&G Investment Management sold 36,688 Halozyme shares in Q4 2021, an estimated $1.5K.
  • M&G Investment Management first reported a position in Halozyme in Q2 2021 and held it in 2 quarters.
  • M&G Investment Management's Halozyme position peaked at $1.65K in Q2 2021.
  • 324 funds tracked by Wall St. Rank held Halozyme as of Q4 2021.

Based on M&G Investment Management's 13F filing for Q4 2021, filed 18 Jan 2022.